AUSTRALIAN CLINICAL LABS LIMITED (ACL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ACL - AUSTRALIAN CLINICAL LABS LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.01

30 Jan
2023

0.000

OPEN

$3.01

0.000

HIGH

$3.01

0

LOW

$3.01

TARGET
$3.80 26.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC .
FNARENA'S MARKET CONSENSUS FORECASTS
ACL: 1
Title FY21
Actual		 FY22
Actual		 FY23
Forecast		 FY24
Forecast
EPS (cps) xxx 88.6 22.4 xxx
DPS (cps) xxx 53.0 N/A xxx
EPS Growth xxx 100.0% - 74.7% xxx
DPS Growth xxx 100.0% N/A xxx
PE Ratio xxx N/A 13.4 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx 59.9% 0.0% xxx

Dividend yield today if purchased 3 years ago: 5,300.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 17.61

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 23/08 - ex-div 41c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 2019202020212022
EPS Basic xxxxxxxxx88.6
DPS All xxxxxxxxx53.0
Sales/Revenue xxxxxxxxx989.3 M
Book Value Per Share xxxxxxxxx115.8
Net Operating Cash Flow xxxxxxxxx284.1 M
Net Profit Margin xxxxxxxxx18.02 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 2019202020212022
Return on Capital Employed xxxxxxxxx113.41 %
Return on Invested Capital xxxxxxxxx50.49 %
Return on Assets xxxxxxxxx32.33 %
Return on Equity xxxxxxxxx113.41 %
Return on Total Capital xxxxxxxxx61.46 %
Free Cash Flow ex dividends xxxxxxxxx238.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

28/10/2022

3

Neutral

$4.15

37.87%

Medlab, a business acquired in December 2021, has been yet another victim of a cyber hack in Australia, Australian Clinical Labs has announced.

Personal information of approximately 223,000 individuals has been affected, while the group's broader system has not been impacted.

Citi suggests while uncertainty lingers about the ultimate negative impact, it believes the reputation risk is likely to be contained as patients tend to use the pathology providers closest to their point-of-care.

Target $4.15. Neutral.

FORECAST
Citi forecasts a full year FY23 EPS of 22.40 cents.
Citi forecasts a full year FY24 EPS of 16.80 cents.
Access Stockbroker Research History >

ACL STOCK CHART

FNArena News on ACL

1
Rudi’s View: Re-Opening Opportunities In Healthcare

Nov 17 2022 - Rudi's View
2
Australian Broker Call *Extra* Edition – Nov 09, 2022

Nov 09 2022 - Daily Market Reports
3
Rudi’s View: Technology’s Moment Of Truth

Nov 03 2022 - Rudi's View
4
Australian Broker Call *Extra* Edition – Oct 28, 2022

Oct 28 2022 - Daily Market Reports
5
In Brief: Consumer Spending, NZ Blueprint, Less Covid Testing

Sep 16 2022 - Weekly Reports

Latest Healthcare services News

1
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
2
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
3
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
4
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
5
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
6
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
7
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals
8
Funding Overhang Weighs On Ramsay’s Rebound

Jun 10 2021 - Australia
9
Treasure Chest: More Pfizer Growth For Ebos Group

May 24 2021 - Treasure Chest
10
Treasure Chest: Demand Pumps Ramsay Health

Mar 03 2021 - Treasure Chest